Profile of:

Stefan Siebert


Professor of Inflammation Medicine and Rheumatology, University of Glasgow Consultant Rheumatologist

Full name: Stefan Siebert

Current country: United Kingdom

Membership level: Full

Type of membership: Member

Number of publications: 14

Comorbidity burden in axial spondyloarthritis: a cluster analysis. (2020)
https://pubmed.ncbi.nlm.nih.gov/31220322/

Physical activity and sedentary behaviour and their associations with clinical measures in axial spondyloarthritis. (2020)
https://pubmed.ncbi.nlm.nih.gov/31848736/

Treatment strategies in axial spondyloarthritis: what, when and how? (2020)
https://pubmed.ncbi.nlm.nih.gov/33053192/

The IL-23/IL-17A Axis in Spondyloarthritis: Therapeutics Informing Pathogenesis? (2020)
https://pubmed.ncbi.nlm.nih.gov/32412997/

Why did IL-23p19 inhibition fail in AS: a tale of tissues, trials or translation? (2019)
https://pubmed.ncbi.nlm.nih.gov/30297330/

Increased risk of hypertension associated with spondyloarthritis disease duration: results from the ASAS-COMOSPA study. (2019)
https://pubmed.ncbi.nlm.nih.gov/30647169/

AxSpA patients who also meet criteria for fibromyalgia: identifying distinct patient clusters using data from a UK national register (BSRBR-AS). (2019)
https://pubmed.ncbi.nlm.nih.gov/31143851/

Non-radiographic axial spondyloarthritis (nr-axSpA) – Advances in classification, imaging and therapy. (2019)
https://pubmed.ncbi.nlm.nih.gov/30788779/

Level of adherence to prescribed exercise in spondyloarthritis and factors affecting this adherence: a systematic review. (2019)
https://pubmed.ncbi.nlm.nih.gov/30649569/

Influence of co-morbid fibromyalgia on disease activity measures and response to TNF inhibitors in axial spondyloarthritis: results from a UK national register. (2018)
https://pubmed.ncbi.nlm.nih.gov/30053166/

The co-occurrence and characteristics of patients with axial spondyloarthritis who meet criteria for fibromyalgia: Results from a UK national register (BSRBR-AS). (2017)
https://pubmed.ncbi.nlm.nih.gov/28622461/

BSR and BHPR Standards, Guidelines and Audit Working Group. BSR and BHPR guideline for the treatment of axial spondyloarthritis (including ankylosing spondylitis) with biologics. (2017)
https://pubmed.ncbi.nlm.nih.gov/27558584/

Ankylosing Spondylitis Patients Display Altered Dendritic Cell and T Cell Populations That Implicate Pathogenic Roles for the IL-23 Cytokine Axis and Intestinal Inflammation. (2016)
https://pubmed.ncbi.nlm.nih.gov/26320138/

Modelling health utility values in Ankylosing Spondylitis: Comparisons of direct and indirect methods. (2015)
https://pubmed.ncbi.nlm.nih.gov/26091596/